Biography

Dr. Peter Sguigna received a bachelor of science degree in biomedical engineering as well as a minor in Mathematics from Texas A&M University, and completed his advanced degrees in medicine, neurology, as well as multiple sclerosis and neuroimmunology from the University of Texas Southwestern. In March of 2020 he was recruited to stay at the University of Texas Southwestern to lead its neuro-ophthalmology initiative within the Department of Neurology. He sees patients with multiple sclerosis, optic neuritis, and other neuro-immunological disorders.

Dr. Sguigna's research interests and activities include advanced diagnostic imaging of neuro-ophthalmological disorders, as well as unraveling the neuro-retinal circuitry in neuroimmunological diseases. He actively works on better ways to distinguish these disorders using non-invasive technology. He uses specialized testing to gain insight into some of the most disabling symptoms for patients with multiple sclerosis. Lastly, he coordinates for clinical trials for better treatment of patients with multiple sclerosis.

Education
Medical School
UT Southwestern Medical School (2014)
Residency
UT Southwestern Medical Center (2018), Neurology
Fellowship
UT Southwestern Medical Center (2020), Multiple Sclerosis

Research Interest
  • Clinical Treatment Trials
  • Medical Devices
  • MOG Antibody Associated Disorders
  • Multiple Sclerosis
  • Neuro-Ophthalmology
  • Neuromyelitis Optica Spectrum Disorder
  • Optic Neuritis
  • Visual Dysfunction

Publications

Featured Publications LegendFeatured Publications

Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population.
Sguigna PV, McCreary MC, Conger DL, Graves JS, Benson LA, Waldman AT, Greenberg BM, J Neuroophthalmol 2020 Aug
Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings.
Perrone CM, Lisak RP, Meltzer EI, Sguigna P, Tizazu E, Jacobs D, Melamed E, Lucas A, Freeman L, Pardo G, Goodman A, Fox EJ, Costello K, Parsons MS, Zamvil SS, Frohman EM, Frohman TC, Neurol Neuroimmunol Neuroinflamm 2019 07 6 4 e582
Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations.
Narayan RN, Wang C, Sguigna P, Husari K, Greenberg B Mult Scler Relat Disord 2018 Oct 27 30-33
Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.
Meltzer E, Sguigna PV, Subei A, Beh S, Kildebeck E, Conger D, Conger A, Lucero M, Frohman BS, Frohman AN, Saidha S, Galetta S, Calabresi PA, Rennaker R, Frohman TC, Kardon RH, Balcer LJ, Frohman EM JAMA Neurol 2017 05 74 5 574-582
Managing Disability in Progressive Multiple Sclerosis.
Dubey D, Sguigna P, Stüve O Curr Treat Options Neurol 2016 Jun 18 6 27
Utilization of video oculography to quantify oculomotor dysfunction in anti-DPPX encephalitis: A case study.
Blackburn K, Vernino S, Sguigna P, Mult Scler Relat Disord 2020 Aug 46 102460
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Hussain R, O'Leary S, Pacheco FM, Zacharias TE, Litvak P, Sguigna P, Marder E, Kia K, Kooner K, Stüve O J. Neurol. 2016 Feb